Latest Breaking News On - Revera phase - Page 1 : comparemela.com

In the phase 2 ReVeRA trial, etripamil nasal spray provided a marked reduction in ventricular rates among patients with atrial fibrillation and rapid ventricular rates.

United kingdomUnited statesCity ofA john cammAmerican heart association scientific sessionsClinical sciences research instituteCardiology clinical academic groupMilestone pharmaceuticals incMilestone pharmaceuticalsGeorge universityBritish heart foundation emeritus professorClinical cardiologyRevera phaseEtripamil nasal sprayNasal spray for afibAtrial fibrillation